Skip to main content
. Author manuscript; available in PMC: 2017 Aug 23.
Published in final edited form as: Eur Urol. 2016 Jun 9;70(6):985–992. doi: 10.1016/j.eururo.2016.05.023

Fig. 2.

Fig. 2

Survival in COU-AA-301 according to treatment arm and CTC response at (A) 4 wk, (B) 8 wk, and (C) 12 wk. Blue lines denote data for patients who received abiraterone + prednisone and red lines patients who received placebo + prednisone. Continuous lines indicate patients with a CTC response and dotted lines patients with no CTC response. CTC = circulating tumor cell; OS = overall survival; CI = confidence interval; Abi = abiraterone; resp = response.